Table 2.
Spearman correlation analysis between patient variables
| Gender | Age | Group | Stage | ||
|---|---|---|---|---|---|
| Gender | Correlation Coefficient | 1 | 0.186* | -0.143 | -0.127 |
| Sig. (2-tailed) | NA | 0.021 | 0.076 | 0.117 | |
| N | 154 | 154 | 154 | 154 | |
| Age | Correlation Coefficient | 0.186 * | 1 | -0.338 ** | -0.254 ** |
| Sig. (2-tailed) | 0.021 | NA | 0 | 0.002 | |
| N | 154 | 154 | 154 | 154 | |
| Group | Correlation Coefficient | -0.143 | -0.338 ** | 1 | 0.827 ** |
| Sig. (2-tailed) | 0.076 | 0 | NA | 0 | |
| N | 154 | 154 | 154 | 154 | |
| Stage | Correlation Coefficient | -0.127 | -0.254 ** | 0.827 ** | 1 |
| Sig. (2-tailed) | 0.117 | 0.002 | 0 | NA | |
| N | 154 | 154 | 154 | 154 |
*. Correlation is significant at the 0.05 level (2-tailed)
**. Correlation is significant at the 0.01 level (2-tailed)
NA: p-values are not applicable for correlations of variables with themselves (diagonal)
Gender: 1-Female, 2-Male; Age: 1->50, 2-<50; Group: 1-BTG, 2-MTG; Stage: 0-BTG. 1-Stage I, 2-Stage II, 3-Stage III, 4-Stage IV